Xenopsin (TFA)

• UNSPSC Description:

  Xenopsin TFA, a neurotensin-like octapeptide from Xenopus laevis skin[1]. Xenopsin TFA is an inhibitor of Tetragastrin stimulated gastric acid secretion[2].

• Target Antigen:

  Neurotensin Receptor

• Type:

  Peptides

• Related Pathways:

  GPCR/G Protein;Neuronal Signaling

• Applications:

  Metabolism-protein/nucleotide metabolism

• Field of Research:

  Metabolic Disease

• Assay Protocol:

  https://www.medchemexpress.com/xenopsin-tfa.html

• Solubility:

  H2O

• Smiles:

  OC(C(F)(F)F)=O.O=C([C@H]1N(CCC1)C([C@H](CCCNC(N)=N)NC([C@H](CCCCN)NC(CNC([C@H]2NC(CC2)=O)=O)=O)=O)=O)N[C@H](C(N[C@@H]([C@@H](C)CC)C(N[C@H](C(O)=O)CC(C)C)=O)=O)CC3=CNC4=C3C=CC=C4

• Molecular Weight:

  1094.19

• References & Citations:

  [1]Sures I, et al. Xenopsin: the neurotensin-like octapeptide from Xenopus skin at the carboxyl terminus of its precursor. Proc Natl Acad Sci U S A. 1984 Jan;81(2):380-4.|[2]Zinner MJ, et al. Effect of xenopsin on blood flow, hormone release, and acid secretion. Am J Physiol. 1982 Sep;243(3):G195-9.

• Shipping Conditions:

  Room temperature

• Clinical Information:

  No Development Reported